Strategic Integration Datavant acquisition unlocks cross sell opportunities by weaving Aetion's real world evidence platform into broader data linking offerings, enabling reach to existing clients and pharma companies seeking end to end evidence pipelines.

Regulatory Engagement Regulatory and payer growth potential leveraging the platform for safety, effectiveness, and value; SURF screening tool and NEST collaborations position Aetion for regulatory submissions and payer analytics deals.

Cloud Marketplace Cloud based procurement acceleration through availability of Aetion Evidence Platform in AWS Marketplace and a scalable tech stack that supports rapid deployment and easier procurement with enterprise IT ecosystems.

Leadership Credibility Leadership credibility and market validation driven by the appointment of a new president and a strong investor roster including Sanofi Ventures, Johnson & Johnson Innovation, McKesson Ventures; CB Insights recognition in synthetic data further boosts enterprise confidence.

Product Expansion Product expansion and strategic partnerships enabling upsell opportunities through the launch of Aetion Activate, expansion of the Evidence Platform, and collaborations such as with Intuitive Surgical for regulatory and real world evidence applications.